...
首页> 外文期刊>European journal of pharmaceutical sciences >Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing
【24h】

Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing

机译:通过熔融沉积建模(FDM)3D印刷制备延长释放患者定制的泼尼松片剂

获取原文
获取原文并翻译 | 示例
           

摘要

Rapid and reliable tailoring of the dose of controlled release tablets to suit an individual patient is a major challenge for personalized medicine. The aim of this work was to investigate the feasibility of using a fused deposition modelling (FDM) based 3D printer to fabricate extended release tablet using prednisolone loaded poly(vinyl alcohol) (PVA) filaments and to control its dose. Prednisolone was loaded into a PVA-based (1.75 mm) filament at approximately 1.9% w/w via incubation in a saturated methanolic solution of prednisolone. The physical form of the drug was assessed using differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD). Dose accuracy and in vitro drug release patterns were assessed using HPLC and pH change flow-through dissolution test.
机译:适合个体患者的控制释放片剂的快速可靠剪裁是个性化药物的主要挑战。 这项工作的目的是研究使用基于融合沉积建模(FDM)的3D打印机的可行性,所述3D打印机使用泼尼松醇负载的聚(乙烯醇)长丝并控制其剂量来制造延长释放片。 通过在饱和甲醇溶液的泼尼松溶液中孵育,在约1.9%w / w的基于PVA的(1.75mm)丝的基于PVA的(1.75mm)的灯丝中。 使用差分扫描量热法(DSC)和X射线粉末衍射(XRPD)评估药物的物理形式。 使用HPLC和pH通过溶解试验评估剂量精度和体外药物释放图案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号